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Background: Jasmonates are plant lipid-derived oxylipins that act as key signaling compounds when plants are
under oxidative stress, but little is known about their functions inmammalian cells. Herewe investigatedwhether
jasmonates could protect human neuroblastoma SH-SY5Y cells against oxidative stress-induced toxicity.
Methods: The cells were pretreatedwith individual jasmonates for 24 h and exposed to hydrogen peroxide (H2O2)
for 24 h. Before the resulting cytotoxicity, intracellular reactive oxygen species (ROS) levels, and mitochondrial
membrane potential were measured. We also measured intracellular glutathione (GSH) levels and investigated
changes in the signaling cascade mediated by nuclear factor erythroid 2-related factor 2 (Nrf2) in cells treated
with 12-oxo phytodienoic acid (OPDA).
Results: Among the jasmonates, only OPDA suppressed H2O2-induced cytotoxicity. OPDA pretreatment also
inhibited the H2O2-induced ROS increase and mitochondrial membrane potential decrease. In addition, OPDA
induced the nuclear translocation of Nrf2 and increased intracellular GSH level and the expression of the Nrf2-
regulated phase II antioxidant enzymesheme oxygenase-1, NADPHquinone oxidoreductase 1, and glutathione re-
ductase. Finally, the cytoprotective effects of OPDA were reduced by siRNA-induced knockdown of Nrf2.
Conclusions: These results demonstrated that among jasmonates, only OPDA suppressed oxidative stress-induced
death of human neuroblastoma cells, which occurred via activation of the Nrf2 pathway.
General signiﬁcance: Plant-derived oxylipin OPDA may have the potential to provide protection against oxidative
stress-related diseases.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
In plants, jasmonates such as 12-oxo phytodienoic acid (OPDA),
jasmonic acid (JA), methyl jasmonate (MeJA), jasmonoyl isoleucine
(JA-Ile), and 12-hydroxy-jasmonic acid (12-OH-JA) are ubiquitously, jasmonic acid; MeJA, methyl
roxy-jasmonic acid; ROS, reac-
ine ligase;GCLC,glutamate cys-
gasemodulatory subunit; Nrf2,
-like ECH-associated protein 1;
eductase 1;GAPDH, glyceralde-
nase;ARE,antioxidantresponse
ources and Informatics, Tokyo
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. This is an open access article underoccurring signaling compounds formed in response to biotic and abiotic
stresses [1]. Jasmonates are synthesized from linolenic acid via an
octadecanoid pathway consisting of several enzymatic steps (Fig. 1).
They are therefore regarded as plant-derived oxylipins similar to
mammalian oxylipins such as prostaglandins and leukotrienes [2].
Biosynthesis of jasmonates is initiated by the release of α-linolenic
acid from the galactolipids of plastid membranes by a galactolipase.
α-Linolenic acid is then converted to OPDA via the three enzymes
13-lipoxygenase, 13-allene oxide synthase, and allene oxide cyclase
[1]. A cyclopentenone ring of OPDA is subsequently reduced by the
peroxisome-localized enzyme 12-oxo-phytodienoic acid reductase 3.
The reaction product then undergoes three rounds of β-oxidation in
the peroxisome, generating JA. MeJA is formed by methylation of JA by
jasmonate methyl transferase. JA is converted by the amino acid conju-
gate synthetase to produce JA-Ile. 12-OH-JA was reported to be
biosynthesized from JA by hydroxylation and an inactivation of JA sig-
naling by this hydroxylation was shown [1,3]. Jasmonates function as
important regulators in plant immunity, germination, and developmentthe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Fig. 1. Structure and biosynthesis of jasmonates. OPDA, 12-oxophytodienoic acid; JA, jasmonic acid; MeJA, methyl jasmonate; 12-OH-JA, 12-hydroxy-jasmonic acid; JA-Ile, jasmonoyl
isoleucine.
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and are found in relatively high amounts in fruits and vegetables such
as tomato, apple, and sweet cherry and rice [5–7]. Jasmonates play an
important role in plant defense against oxidative stress caused by
wounding or ozone exposure by regulating gene expression or second-
ary metabolism [8,9]. Among jasmonates, OPDA is a type of reactive
electrophile species (RES) [10]. In plants, RES contribute to protection
of cells underwounding stress by increasing the expression of genes re-
lated to detoxiﬁcation functions and chaperones [10].
Neuronal cells are thought to be more sensitive to oxidative stress
than cells in other tissues [11], and oxidative stress is implicated in
human neurological diseases including Parkinson's disease [12].
Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2)
cause neuronal damage [13,14]. To prevent oxidative stress, several non-
enzymatic and enzymatic factors that prevent ROS formation or
scavenge radicals are present in the body, such as glutathione (GSH)
[15,16] and glutamylcysteine ligase (GCL), which is the rate-limiting en-
zyme for GSH synthesis [17]. Induction of GCL expression is associated
with an increase in nuclear factor erythroid 2-related factor 2 (Nrf2),
which regulates the transcription of phase II and other enzymes that re-
duce oxidative stress [18]. Under normal conditions, Nrf2 is degraded
through the ubiquitin-proteasome pathway by binding to Kelch-like
ECH-associated protein 1 (Keap1) because Keap1 act as an adaptormol-
ecule for the E3 ubiquitin ligase [19]. Upon stimulation with oxidative
stress or chemopreventive compounds, Nrf2 dissociates from Keap1and translocates to the nucleus where it binds to the cis-acting antioxi-
dant response element (ARE) in the promoter regions of genes encoding
antioxidant proteins; Nrf2 binding thereby activates the expression of
these genes [19,20]. During the cellular response to oxidative stress,
Nrf2 regulates the transcription of downstream genes such as γ-GCL,
heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1
(NQO1), and glutathione reductase [21–24]. Therefore Nrf2 activation
is associated with neuroprotective effects [25–29].
Jasmonates are structurally similar to mammalian oxylipins includ-
ing prostaglandins, which are also synthesized from membrane-
derived fatty acids. It has been reported that prostaglandins regulate in-
ﬂammatory responses and vascular homeostasis [30–32], and some re-
ports have suggested that jasmonates have anti-inﬂammatory activity
in mammalian cells [33,34]. Recently the anti-cancer properties of
jasmonates have been intensively studied [35–37]. In fact, plants with
high content of JA such as Viscum album are of pharmaceutical interest
in order to prepare anticancer drugs [38]. However, little is known
about jasmonate effects against oxidative stress in neuronal cells.
The aim of our study was to investigate whether jasmonates affect
oxidative stress-induced cell damage and cell death in human neuro-
blastoma SH-SY5Y cells. We found that one of the jasmonates, OPDA,
suppressed H2O2-induced oxidative damage and cell death. The effect
of OPDA was due to Nrf2 activation and subsequent expression of anti-
oxidants and phase II detoxiﬁcation enzymes, which resulted in inhibi-
tion of ROS production and reduced oxidative damage.
Fig. 2. OPDA decreases H2O2-induced cytotoxicity. SH-SY5Y cells were pretreated with
(A) 30 μM OPDA, JA, MeJA, JA-Ile, or 12-OH-JA for 24 h and (B) 7.5, 15, or 30 μM OPDA
for 24 h. After the medium was changed, the cells were exposed to 200 μMH2O2 for 24 h.
Cytotoxicity was assessed by LDH assay. Values indicate themean± S.E.M. from three sep-
arate experiments. ##p b 0.01 versus control; *p b 0.05; **p b 0.01 versus H2O2 alone.
OPDA, 12-oxophytodienoic acid; JA, jasmonic acid; MeJA, methyl jasmonate; 12-OH-JA,
12-hydroxy-jasmonic acid; JA-Ile, jasmonoyl isoleucine; LDH, lactate dehydrogenase.
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2.1. Materials
Dulbecco's Modiﬁed EagleMedium/NutrientMixture F-12 (1:1 (v/v),
DMEM/F-12), 5-(and-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein
diacetate acetyl ester (CM-H2DCFDA), Lipofectamine 2000, and Lipofec-
tamine RNAiMAX were obtained from Life Technologies. Fetal bovine
serum was obtained from Cell Culture Bioscience. cis-OPDA, (±)-JA,
and (±)-MeJA were obtained from Cayman Chemical. (-)-JA-Ile and
(±)-12-OH-JA were purchased from OlchemIm Ltd. (+)-7-iso-JA-Ile
was synthesized as indicated in Chen et al. [39]. H2O2 and the LDH-
Cytotoxic Test were obtained from Wako Pure Chemicals. GSH-Glo
Glutathione Assay was obtained from Promega. Antibodies against Nrf2
and GCLM were obtained from Santa Cruz Biotechnology. Anti-lamin
was obtained from Cell Signaling. Anti-HO-1 was obtained from Biomol.
Antibodies against GCLC, β-actin, NQO1, and glutathione reductase were
obtained from Abcam. Horseradish peroxidase-conjugated secondary
antibodies and ECL Prime Western Blotting Detection Reagent
were from GE Healthcare. NE-PER Nuclear and Cytoplasmic Extraction
Reagent and Micro BCA Protein Assay kit were from Pierce. The
mitochondria-selective dye JC-1 was obtained from Immunochemistry
Technologies. Protease inhibitor cocktail was purchased from Sigma.
RNeasy Mini kit and All Stars Negative Control siRNA were obtained
from Qiagen. ReverTra Ace was from TOYOBO.
2.2. Cell culture
Human neuroblastoma SH-SY5Y cells were obtained from DS
Pharma Biomedical. Cells were grown in DMEM/F-12 containing 10%
fetal bovine serum. Cells were maintained at 37 °C in a humidiﬁed
atmosphere with 5% CO2. Cells were plated at appropriate density ac-
cording to each experimental scale. Cellswere treatedwith various con-
centrations of jasmonates for various times. Control cells were treated
with medium lacking jasmonates. For oxidative stress treatment, cells
were pretreated with each of several jasmonates for 24 h. After theme-
dium was changed to that without jasmonates, the cells were exposed
to 200 μM H2O2 for various times. Control cells were treated with the
medium without jasmonates and H2O2.
2.3. Cytotoxicity assay
Cells dying by apoptosis or necrosis release lactate dehydrogenase
(LDH) into the culture medium [40]. The amount of LDH in themedium
was assayed with a LDH-cytotoxic test. As a positive control, cells were
completely lysed using 2% (v/v) Triton X-100 to give maximum LDH re-
lease.Wemeasured LDH level at 24 h after H2O2 treatment because LDH
was not detected within the ﬁrst 8 h of treatment.
2.4. Measurement of intracellular ROS
ROSweremeasured using the oxidation-sensitive ﬂuorescent probe,
CM-H2DCFDA. SH-SY5Y cells were incubated with CM-H2DCFDA
(10 μM) for 30 min at 37 °C in the dark. Then the cells were harvested
and analyzed on a ﬂow cytometer.
2.5. Measurement of mitochondrial membrane potential
Changes in mitochondrial membrane potential were analyzed using
JC-1, a lipophilic cation that selectively enters mitochondria and revers-
ibly changes color from green to red depending on the membrane
potential. In healthy cells with highmitochondrialmembrane potential,
JC-1 forms red ﬂuorescent complexes that are detected in FL2 (488 nm
excitation; 590 nm emission); in damaged cells with lowmitochondrial
membrane potential, JC-1 exists inmonomeric formwith green ﬂuores-
cence that is detected in FL1 (488nmexcitation; 525 nmemission) [41].SH-SY5Y cells were harvested and incubated with JC-1 for 15 min
at 37 °C. Cells were then washed twice with phosphate-buffered saline
and analyzed using a ﬂow cytometer (excitation wavelength, 488 nm).
We created log FL1 (x-axis) versus log FL2 (y-axis) dot plots and set two
regions, 1 and 2, which correspond to the same areas in all dot plots.
Cells were then counted in region 1 and in region 2.
2.6. Immunoblotting
Cells were solubilized using NE-PER Nuclear and Cytoplasmic Ex-
traction Reagent or RIPA buffer with 1% protease inhibitor cocktail for
nuclear protein extraction or whole-cell protein extraction, respective-
ly. Protein concentrationswere determined using theMicro BCA Protein
Assay kit. The proteins were subjected to sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and subsequently transferred to a
polyvinylidene diﬂuoride membrane. The membrane was blocked
with polyvinylidene diﬂuoride blocking reagent and incubated over-
night at 4 °C with a primary antibody against Nrf2, lamin, GCLM,
GCLC, HO-1, NQO1, glutathione reductase, or β-actin. The membrane
was washed in phosphate-buffered saline containing 0.1% (v/v)
Tween-20 and incubated for 1 h at room temperature with horseradish
peroxidase-conjugated secondary antibody. Chemiluminescence sig-
nals generated by ECL PrimeWestern Blotting Detection Reagent were
detectedwith the Image Quant LAS 3000 CCD camera system (Fujiﬁlm).
2.7. Quantitative real-time PCR analysis
Total RNA was extracted with the RNeasy system, which includes a
DNase step, and cDNAwas synthesized using random hexamer primers
and ReverTra Ace reverse transcriptase. Quantitative real-time PCR was
Fig. 3.OPDA reduces the H2O2-induced depolarization of themitochondrial membrane potential. SH-SY5Y cells were preincubatedwith 30 μMOPDA for 24 h followed by treatment with
200 μMH2O2 for 24 h. The cells were then labeledwith JC-1 and analyzed by ﬂow cytometry. Dot plots show the number of cells emitting red ﬂuorescence (FL2) versus green ﬂuorescence
(FL1). OPDA, 12-oxophytodienoic acid.
Fig. 4.OPDA attenuates H2O2-induced cytotoxicity. SH-SY5Y cells were preincubatedwith
30 μM OPDA for 24 h followed by treatment with 200 μM H2O2 for 2 h. The cells were la-
beled with the ﬂuorescent probe CM-H2DCFDA, and intracellular ROS accumulation was
determined by measuring ﬂuorescence intensity using a ﬂow cytometer. Values
(mean ± S.E.M., n = 3) are expressed as the fold induction relative to untreated cells.
#p b 0.05 versus control; **p b 0.01 versus H2O2 alone. OPDA, 12-oxophytodienoic acid;
ROS, reactive oxygen species.
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Biosystems). The data presented are normalized to GAPDH transcripts.
The following primers and probes were used (5′ to 3′). Nrf2 primers:
Nrf2 forward (fwd), TACTCCCAGGTTGCCCACA; Nrf2 reverse (rev),
CATCTACAAACGGGAATGTCTGC; Nrf2 probe (FAM-TAMRA), TCAGAT
GCTTTGTACTTTGATGACTGCATGC. HO-1 primers: HO-1 fwd, CTTCTT
CACCTTCCCCAACATT; HO-1 rev, GCAGTCTTGGCCTCTTCTATCAC; HO-1
probe, AGATGACTCCCGCAGTCAGGCA. NQO1 primers: NQO1 fwd,
CCTGGAAGGATGGAAGAAACG; NQO1 rev, AGAATCCTGCCTGGAAGTTT
AGG; NQO1 probe, ACACCACTGTATTTTGCTCCAAGCAGCC. GCLC
primers: GCLC fwd, TCTCTAATAAAGAGATGAGCAACATGC; GCLC rev,
TTGACGATAGATAAAGAGATCTACGAA; GCLC probe, CAGGAGATGATC
AATGCCTTCCTGCAAC. GCLM primers: GCLM fwd, GTTCAGTCCTTGGA
GTTGCACA; GCLM rev, CCCAGTAAGGCTGTAAATGCTC; GCLM probe,
GCTGGATTCTGTGATCATTGCTTCACC. Glutathione reductase primers:
glutathione reductase fwd, AGTGATCCCAAGCCCACAATAG; glutathione
reductase rev, CCATCGCTGGTTATTCCTAAGC; glutathione reductase
probe, AAAAAGTACACCGCCCCACACATCCT.
2.8. Measurement of GSH level
Intracellular GSH level was measured using GSH-Glo Glutathione
Assay and normalized to total cell protein.
2.9. ARE assay
For the stable ARE-driven reporter system, the pGL4 vector
(Promega), containing a hygromycin selectable marker, was used togenerate ARE reporter plasmids. Brieﬂy, a DNA fragment containing
three copies of the ARE (TTTCTGCTGCGTCATGTTTG) sequence was
cloned upstream of the promoter-luciferase transcriptional unit of
vector pGL4, resulting in pGL4-3 × ARE. Plasmid pGL4-3 × AREwas sta-
bly transfected into SH-SY5Y cells using Lipofectamine 2000, and
transfected cells were selected using 75 μg/ml hygromycin. Luciferase
activity was measured using the Bright-Glo Luciferase Assay System.
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SH-SY5Y cells were transiently transfected with Nrf2 siRNA
(5′-CCCATTGATGTTTCTGATCTA-3′) or All Stars Negative Control siRNA
using Lipofectamine RNAiMAX.
3. Results
3.1. OPDA decreases H2O2-induced cytotoxicity
Weﬁrst examined the role of OPDA, JA,MeJA, JA-Ile, and 12-OH-JA in
oxidative stress-induced cytotoxicity in human neuroblastoma
SH-SY5Y cells. Cells were pretreated with jasmonates for 24 h and
exposed to H2O2 for an additional 24 h (Fig. 2 and supplemental
Fig. 1). H2O2 treatment signiﬁcantly increased LDH activity in the cell
culture medium, indicating that cell death occurred. Only pretreatment
with OPDA signiﬁcantly reduced H2O2-induced cell death in a
concentration-dependent manner (Fig. 2A and B), whereas all otherFig. 5.OPDA induces the Nrf2 signaling pathway. (A) SH-SY5Y cells transfectedwith the ARE re
Luciferase activities were then determined. Values (mean ± S.E.M., n= 3) are expressed as th
were treatedwith 30 μMOPDA for 1, 2, 3, or 6 h. Nuclear Nrf2was determined by immunoblotti
6 h. Intracellular ROS levelwas determined bymeasuring theﬂuorescence of cells labeledwith C
untreated cells at each time point. *p b 0.05, **p b 0.01 versus control. OPDA, 12-oxophytodieno
JA-Ile, jasmonoyl isoleucine; ARE, antioxidant response element; Nrf2, nuclear factor erythroidjasmonates showed no cytoprotective effects. These results indicated
that, among jasmonates, OPDA has unique properties that protect
SH-SY5Y cells against oxidative stress.
3.2. OPDA suppresses the H2O2-induced reduction of the mitochondrial
membrane potential
Cell death is accompanied by the collapse of the mitochondrial
membrane potential. Thus, we used JC-1 dye to detect the mitochon-
drial membrane potential of SH-SY5Y cells with or without OPDA pre-
treatment followed by H2O2 exposure. In healthy cells with high
mitochondrial membrane potential, JC-1 forms complexes that release
red ﬂuorescence (Fig. 3, regions A1, B1, C1, and D1). In dying cells
with low mitochondrial membrane potential, JC-1 exists as a monomer
and releases green ﬂuorescence (Fig. 3, regions A2, B2, C2, and D2).
Treatment of SH-SY5Y cells with H2O2 resulted in a signiﬁcant change
in the ﬂuorescence of cells having a high (Fig. 3, region A1 versus C1)
or low mitochondrial membrane potential (Fig. 3, region A2 versusporter plasmidwere treatedwith 15 or 30 μMOPDA, JA, MeJA, JA-Ile, or 12-OH-JA for 24 h.
e fold induction relative to untreated cells as a control. **p b 0.01 versus control. (B) Cells
ng. Laminwas used as a loading control. (C) Cellswere treatedwith 30 μMOPDA for 1, 3, or
M-H2DCFDA. Values (mean± S.E.M.,n=3) are expressed as the fold induction relative to
ic acid; JA, jasmonic acid; MeJA, methyl jasmonate; 12-OH-JA, 12-hydroxy-jasmonic acid;
2-related factor 2.
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(Fig. 3, region A1), but upon incubation with H2O2 this was reduced to
32% (Fig. 3, region C1). Notably, pretreatment with OPDA did not affect
the percentage of cells having a high or lowmembrane potential (Fig. 3,
regions A1 versus B1, and A2 versus B2). However, pretreatment with
OPDA signiﬁcantly countered the deleterious effects of H2O2 on the
membrane potential (Fig. 3, regions C1 versus D1, and C2 versus D2).
These results suggested that OPDA exerts its cytoprotective effects by
preserving mitochondrial function.
3.3. OPDA attenuates H2O2-induced oxidative stress
To determine whether OPDA affects the H2O2-induced death of
SH-SY5Y cells, we measured cellular ROS levels using the ﬂuorescent
dye CM-H2DCFDA. Exposure of SH-SY5Y cells to H2O2 at 200 μM for
2 h caused an increase in intracellular ROS levels (Fig. 4). However,Fig. 6. OPDA increases the expression of antioxidant enzymes. (A) SH-SY5Y cells were treated
quantitative real-time PCR. Values (mean ± S.E.M., n = 3) are expressed as the fold inducti
with 30 μMOPDA for 6 or 24 h. GCLM and GCLC protein levels were determined by immunoblo
experiments is shown. β-actin was used as a loading control. (C) Cells were treated with 15 or
expressed as the fold induction relative to untreated cells. *p b 0.05, **p b 0.01 versus control
HO1, NQO1, and glutathione reductase were determined by quantitative real-time PCR. Value
*p b 0.05, **p b 0.01 versus control. (E) Cells were treated with 30 μMOPDA for 6 or 24 h. Level
ting.β-actinwas used as a loading control. A representative blot from three independent experi
subunit; GCLM, glutamate cysteine ligase modulatory subunit; HO-1, heme oxygenase-1; NQOpretreatment of the cells with 30 μM OPDA for 24 h attenuated the
H2O2-induced ROS production, suggesting that OPDA pretreatment in-
duced a cellular antioxidative response.
3.4. OPDA activates the Nrf2 pathway
Because Nrf2 signaling regulates cellular antioxidant response by
promotingARE-dependent gene expression [19],we examinedwhether
OPDA protected cells from intracellular oxidative stress by activating
the Nrf2 signaling pathway. First, we determined whether jasmonates
in general enhanced ARE activity using a luciferase reporter assay.
Whereas JA, MeJA, JA-Ile, and 12-OH-JA did not enhance ARE activity,
OPDA did increase ARE activity (Fig. 5A).
We then examined the effect of OPDA on the intracellular localiza-
tion of Nrf2 in SH-SY5Y cells. OPDA increased Nrf2 nuclear translocation
after only 1 h of OPDA treatment (Fig. 5B). Theseﬁndings suggested thatwith 15 or 30 μM OPDA for 6 or 24 h. GCLM and GCLC mRNA levels were determined by
on relative to untreated cells. *p b 0.05, **p b 0.01 versus control. (B) Cells were treated
tting. β-actin was used as a loading control. A representative blot from three independent
30 μM OPDA for 24 h. Total GSH level was measured. Values (mean ± S.E.M., n= 3) are
. (D) Cells were treated with 15 or 30 μM OPDA for 6 or 24 h. Levels of mRNAs encoding
s (mean ± S.E.M., n = 3) are expressed as the fold induction relative to untreated cells.
s of the proteins HO1, NQO1, and glutathione reductase were determined by immunoblot-
ments is shown. OPDA, 12-oxophytodienoic acid; GCLC, glutamate cysteine ligase catalytic
1, NAD(P)H quinone oxidoreductase 1.
Fig. 6 (continued).
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residues by ROS and electrophiles changes the conformation of Keap1
[19,20,42,43] and thus induces Nrf2 signaling cascade. Here we investi-
gatedwhether OPDA could promote the production of intracellular ROS.
Intracellular ROS level increased slightly at 1–3 h after treatment with
OPDA and then decreased to the basal level at 6 h (Fig. 5C), suggesting
that transient ROS production could be involved in Nrf2 pathway
activation.
3.5. OPDA increased the expression of antioxidant enzymes
Activation of Nrf2 signaling leads to up-regulation of genes impor-
tant for cellular antioxidant defense activity [19]. One of these Nrf2 tar-
gets is GCL, which consists of modulatory (GCLM) and catalytic (GCLC)
subunits. In SH-SY5Y cells, we investigated whether mRNA and protein
levels of these GCL subunits were altered by OPDA. OPDA treatment sig-
niﬁcantly induced bothmRNA and protein levels of GCLM (Fig. 6A), and
although the GCLC mRNA level increased, the protein level did not
change (Fig. 6B). Because OPDA changed the mRNA and protein levels
of GCLM, we also measured intracellular GSH levels at 24 h after OPDAtreatment. OPDA induced a dose-dependent increase in GSH level
(Fig. 6C). In addition to measuring GSH synthesis, we examined the ex-
pression of other phase II antioxidant/detoxiﬁcation enzymes such as
HO-1, NQO1, and glutathione reductase in SH-SY5Y cells after treatment
with OPDA for 6 and 24 h. OPDA increased both mRNA and protein
levels of HO-1, NQO1, and glutathione reductase after 6 and 24 h
(Fig. 6D and E), suggesting that OPDA initiates the cellular antioxidative
defense system via activation of Nrf2 signaling.
3.6. The Nrf2 pathway is involved in the cytoprotective effect of OPDA
To conﬁrm the contribution of Nrf2 signaling to the suppressive ef-
fects of OPDA on H2O2-induced cytotoxicity, we transiently transfected
SH-SY5Y cells with Nrf2 siRNA and evaluated protein expression levels
of Nrf2 and Nrf2 target genes and H2O2-induced cell death. Nrf2 siRNA
reduced the OPDA-induced nuclear translocation of Nrf2 (Fig. 7A). We
also investigated whether Nrf2 siRNA transfection suppressed OPDA-
induced up-regulation of GCLM, HO-1, NQO1, and glutathione reduc-
tase. OPDA-induced expression of these genes was blocked by Nrf2
siRNA (Fig. 7B). We further examined whether the cytoprotective
Fig. 7. Antioxidant protection of neuronal SH-SY5Y cells by OPDA is Nrf2 dependent. (A) SH-SY5Y cells were transiently transfected with negative control (NC) or Nrf2 siRNAs for 24 h,
followed by treatment with 30 μM OPDA for 24 h. Nuclear Nrf2 was detected by immunoblotting. Lamin was used as a loading control. (B) Cells were transiently transfected with NC
or Nrf2 siRNA for 24 h and were then treated with 30 μMOPDA for an additional 6 or 24 h. Levels of the proteins GCLM, HO1, NQO1, and glutathione reductase were measured by immu-
noblotting. β-actin was used as a loading control. A representative blot from three independent experiments is shown. (C) Cells were transiently transfected with NC or Nrf2 siRNAs for
24 h, followed by treatmentwith 30 μMOPDA for 24 h. After themediumwas changed, cells were exposed to H2O2 for an additional 24 h. Cytotoxicity was assessed by LDH assay. Values
indicate the mean ± S.E.M. from three separate experiments. *p b 0.05 versus H2O2-treated cells transfected with control siRNA. OPDA, 12-oxophytodienoic acid; Nrf2, nuclear factor
erythroid 2-related factor 2; GCLM, glutamate cysteine ligase modulatory subunit; HO-1, heme oxygenase-1; NQO1, NAD(P)H quinone oxidoreductase 1.
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induced cytoprotection against H2O2 was suppressed by Nrf2 knock-
down in SH-SY5Y cells (Fig. 7C). These data suggested that Nrf2 activa-
tion and the subsequent upregulation of genes encoding antioxidative
enzymes are crucial for the cytoprotective properties of OPDA.
4. Discussion
Our results are the ﬁrst to demonstrate that the plant-derived
oxylipin OPDA has cytoprotective and antioxidative effects via activa-
tion of Nrf2 signaling in human neuroblastoma SH-SY5Y cells. Among
the tested jasmonates, only OPDA induced Nrf2/ARE activation and
showed subsequent cytoprotective effects. Electrophiles such as prosta-
glandin J2, epigallocatechin-3-gallate and sulforaphane induceNrf2/ARE
activation by inhibiting Keap1-mediated Nrf2 degradation, which
protect cells from subsequent oxidative stress [44–46]. This inhibitionrequires posttranslational modiﬁcation of Keap1 by electrophiles or
ROS [19,20]. It is reported that H2O2 treatment, which induces ROS
production, results in transient Nrf2 activation [47]. Because OPDA
induced transient production of ROS and it can act as an electrophile, a
potential modiﬁcation of Keap1 may be related to Nrf2/ARE activation.
As shown in Fig. 5B and C, Nrf2 activation continued after ROS produc-
tion ceased, and thus direct modiﬁcation of Keap1 by OPDA—acting as
an electrophile—might be responsible for Nrf2 activation. This is consis-
tent with the result that none of the other jasmonates, which are not
electrophiles, could activate Nrf2/ARE signaling. Although the precise
mechanisms of OPDA action remain to be elucidated, our results dem-
onstrate that Nrf2 activation may be associated with the cytoprotective
properties of OPDA.
Activation of Nrf2 in vivo is linked to the cytoprotective effects seen in
neuronal cells in model of Parkinson's disease and of brain ischemia
[48–50]. In contrast, Nrf2 deﬁciency exacerbates neuronal damage in
3421N. Taki-Nakano et al. / Biochimica et Biophysica Acta 1840 (2014) 3413–3422Parkinson's disease and ischemic injury models [51,52]. As shown in
Figs. 6 and 7, Nrf2 activation by OPDA induced the expression of the
antioxidative enzymes HO-1, NQO1, and glutathione reductase and the
subsequent generation of intracellular GSH. GSH is the most abundant
non-protein thiol in mammalian cells and acts as a major reducing
agent that tightly regulates redox status [53] and is an important
molecule for protecting against neurodegenerative diseases [54]. The
sulfhydryl form GSH can reduce H2O2 via glutathione peroxidase to
form disulﬁde-linked GSH. GSH can be regenerated from disulﬁde-
linked GSH by glutathione reductase with NADPH [53,55]. Hence, gluta-
thione reductase is an important enzyme for maintaining a redox
balance in cells. HO-1 serves as one of the defense systems against
oxidative damage by converting toxic heme into carbon monoxide,
iron, and biliverdin [56]. Biliverdin is subsequently converted to bilirubin
through the action of biliverdin reductase, and this molecule serves as a
potent antioxidant [56]. Up-regulation of HO-1 expression by chemical
treatment or adenovirus-mediated overexpression in brain is therapeu-
tic in models of neurodegenerative diseases [57,58]. NQO1 is a ﬂavopro-
tein that catalyzes the two-electron reduction of quinones to protect
against ROS generation [59] and is believed to prevent severe oxidative
damage in various neuronal disorders [60,61]. Because OPDA induced
the expression of various Nrf2 related antioxidative enzymes in human
neuroblastoma cells, we expect that it could be therapeutically useful
to protect against oxidative stress-related neuronal diseases. We applied
24 h for pretreatment with OPDA because the cytoprotective effects
against H2O2were observed after 24 h but not 6 h, suggesting that longer
pretreatment is required to accumulate suitable levels of antioxidants
and cytoprotective proteins. Consistently, GSH increased signiﬁcantly
after 24 h of OPDA treatment but not 6 h.
OPDA induced an Nrf2-dependent antioxidative response, which
may have contributed to the observed decrease in H2O2-induced ROS
levels. Intracellular ROS accumulation induces mitochondrial mem-
brane depolarization, which is linked to mitochondrial dysfunction in
neurodegenerative diseases [62–64]. Antioxidants, however, prevent
the loss of mitochondrial membrane potential [65]. We demonstrated
that OPDA treatment suppressed the H2O2-induced reduction in mito-
chondrial membrane potential, which may be due to the ability of
OPDA to inhibit H2O2-induced ROS accumulation. Preservation of mito-
chondrial function may be related to cytoprotective effects of OPDA.
We previously reported that the OPDA signaling pathway functions
independently of JA/MeJA signaling and is required for the wounding
response in Arabidopsis [8].Moreover, OPDA, but not JA, regulates cellu-
lar redox homeostasis by binding to cyclophilin 20-3 in response to cel-
lular stress in plants [66]. Our present study demonstrates that only
OPDA, among all jasmonates tested, has a cytoprotective effect through
Nrf2 activation inmammalian cells. Although further studies are needed
to explore the cytoprotective effects of OPDA in other cell types, it is in-
teresting that OPDA has a unique cytoprotective function in mammals
as well as in plants. A variety of plant-derived nutraceuticals have dem-
onstrated cytoprotective activity against oxidative stress through Nrf2
activation in SH-SY5Y or PC12 cells [67–72]. Additionally, the potential
therapeutic value of each of these compounds in neurogenerative dis-
eases has been discussed [73]. OPDA is ubiquitous in higher plants
such as Arabidopsis, tomato, maize, and soybean [5,74–76]. Although
further investigations about the absorption, metabolism, and ability of
OPDA to cross the blood–brain barrier are needed, intake of natural
foods containing OPDA could potentially help to prevent oxidative
stress-mediated neurodegenerative diseases. It also has been reported
that JA and MeJA have anti-cancer activities [36–38]. Therefore, OPDA,
in addition to other jasmonates reported so far, may also be of pharma-
ceutical or medicinal interests as a plant-derived oxylipin.
5. Conclusions
Our ﬁndings indicate that OPDA rescues neuronal cells from H2O2-
induced death by increasing cellular antioxidative defenses, asdemonstrated by its ability to regulate ROS production and mitochon-
drial membrane potential via activation of the Nrf2 pathway. Therefore
OPDA has the potential to provide protection against oxidative stress-
related diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2014.09.003.Acknowledgments
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